These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 27276566)

  • 1. A New Label for Mifepristone.
    Greene MF; Drazen JM
    N Engl J Med; 2016 Jun; 374(23):2281-2. PubMed ID: 27276566
    [No Abstract]   [Full Text] [Related]  

  • 2. Mifepristone label laws and trends in use: recent experiences in four US states.
    Sheldon WR; Winikoff B
    Contraception; 2015 Sep; 92(3):182-5. PubMed ID: 26116033
    [No Abstract]   [Full Text] [Related]  

  • 3. From qualified physician to licensed health care professional: the time has come to change mifepristone's label.
    Foster AM; Jackson CB; LaRoche KJ; Simmonds K; Taylor D
    Contraception; 2015 Sep; 92(3):200-2. PubMed ID: 26134281
    [No Abstract]   [Full Text] [Related]  

  • 4. Sixteen Years of Overregulation: Time to Unburden Mifeprex.
    ; Raymond EG; Blanchard K; Blumenthal PD; Cleland K; Foster AM; Gold M; Grossman D; Pendergast MK; Westhoff CL; Winikoff B
    N Engl J Med; 2017 Feb; 376(8):790-794. PubMed ID: 28225670
    [No Abstract]   [Full Text] [Related]  

  • 5. Comment: analysis of severe adverse events related to the use of mifepristone as an abortifacient.
    Hausknecht RU
    Ann Pharmacother; 2006 Apr; 40(4):785-6; author reply 786. PubMed ID: 16569806
    [No Abstract]   [Full Text] [Related]  

  • 6. Mifepristone (Mifeprex) label changes.
    Med Lett Drugs Ther; 2016 Apr; 58(1493):55-6. PubMed ID: 27101211
    [No Abstract]   [Full Text] [Related]  

  • 7. Aligning mifepristone regulation with evidence: driving policy change using 15 years of excellent safety data.
    Cleland K; Smith N
    Contraception; 2015 Sep; 92(3):179-81. PubMed ID: 26093188
    [No Abstract]   [Full Text] [Related]  

  • 8. State Restrictions on Mifepristone Access - The Case for Federal Preemption.
    Zettler PJ; Sarpatwari A
    N Engl J Med; 2022 Feb; 386(8):705-707. PubMed ID: 35020981
    [No Abstract]   [Full Text] [Related]  

  • 9. Refusal clauses and the weldon amendment: inherently unconstitutional and a dangerous precedent.
    Green J
    J Leg Med; 2005 Sep; 26(3):401-15. PubMed ID: 16126638
    [No Abstract]   [Full Text] [Related]  

  • 10. Comment: analysis of severe adverse events related to the use of mifepristone as an abortifacient.
    Svedas E; Maciulaitis R; Stakisaitis D
    Ann Pharmacother; 2006 Apr; 40(4):784; author reply 784-5. PubMed ID: 16595574
    [No Abstract]   [Full Text] [Related]  

  • 11. Time to Reevaluate U.S. Mifepristone Restrictions.
    Henney JE; Gayle HD
    N Engl J Med; 2019 Aug; 381(7):597-598. PubMed ID: 31242357
    [No Abstract]   [Full Text] [Related]  

  • 12. Her accidental legacy.
    Rosenberg D
    Newsweek; 2003 Oct; 142(15):64. PubMed ID: 16124192
    [No Abstract]   [Full Text] [Related]  

  • 13. Mifepristone and misoprostol for early abortion.
    JNMA J Nepal Med Assoc; 2006; 45(161):I. PubMed ID: 17160090
    [No Abstract]   [Full Text] [Related]  

  • 14. Time to misoprostol after mifepristone: still a bone of contention!
    Rajaram S; Mehta S; Goel N
    BJOG; 2011 Apr; 118(5):629; author reply 629-30. PubMed ID: 21392227
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of misoprostol in pregnancy.
    Hale RW; Zinberg S
    N Engl J Med; 2001 Jan; 344(1):59-60. PubMed ID: 11136964
    [No Abstract]   [Full Text] [Related]  

  • 16.
    Fuleihan C
    Am J Law Med; 2020 Nov; 46(4):507-517. PubMed ID: 33413017
    [No Abstract]   [Full Text] [Related]  

  • 17. Impossible? Outlawing state safety laws for generic drugs.
    Glantz LH; Annas GJ
    N Engl J Med; 2011 Aug; 365(8):681-3. PubMed ID: 21830958
    [No Abstract]   [Full Text] [Related]  

  • 18. Mifepristone for termination of early pregnancy.
    FDA Consum; 2000; 34(6):7. PubMed ID: 11192820
    [No Abstract]   [Full Text] [Related]  

  • 19. Is there evidence to decrease the approved dose of 600 mg of mifepristone for medical abortion?
    Lièvre M; Sitruk-Ware R
    Contraception; 2010 Jun; 81(6):553-4. PubMed ID: 20472128
    [No Abstract]   [Full Text] [Related]  

  • 20. Mifepristone (RU 486).
    Med Lett Drugs Ther; 2000 Oct; 42(1091):101-2. PubMed ID: 11056043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.